Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2019 | Acute pulmonary toxicity in lung cancer

Marina Garassino • 3 Jul 2019
ELCC 2019
Lung Cancer

In this video, Marina Garassino, MD, National Cancer Institute of Milan, Milan, Italy, reports that oncologists should be aware of the rare, but potentially life-threatening manifestation of pulmonary toxicities in lung cancer patients. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.

More from Marina Garassino

3:25
PACIFIC 6: durvalumab after sCRT in patients with NSCLC
Marina Garassino • 18 Mar 2021
4:28
Combining chemotherapy and immunotherapy: key trials in lung cancer
Marina Garassino • 18 Mar 2021
3:04
TERAVOLT: outcomes for patients with COVID-19 and lung cancer
Marina Garassino • 18 Mar 2021
1:43
Novel targets for NSCLC
Marina Garassino • 18 Mar 2021

Related Videos

0:45
Assessing treatment options for lung cancer with interstitial lung disease
Matthew Hatton • 18 Apr 2024
2:26
Targeting KRAS mutations in lung cancer
Thomas Newsom-Davis • 18 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals